Details of the Drug

General Information of Drug (ID: DMI7SUU)

• Drug Name: NEO100

Indication

Disease Entry	ICD 11	Status	REF
Glioblastoma multiforme	2A00.0	Phase 1/2	[1]
Malignant glioma	2A00.0	Phase 1/2	[2]
Recurrent malignant glioma	2A00.0	Phase 1/2	[3]

• Cross-matching ID:
  PubChem CID: 369312
  TTD ID: D0T7OE
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of Neonc technologies.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)